Evidence map›Paper›PMID 42391295›Full record

ArticlePloS one2026

Deep learning based two-way feature depiction model for brain tumor detection.

Shabana Urooj, Kiran Napte, Najah Alsubaie

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shabana UroojDepartment of Electrical Engineering, College of Engineering, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-1477-8759
Kiran NapteDepartment of Electronics and Telecommunication, PCET's Pimpri Chinchwad College of Engineering and Research, Ravet, Pune, India.ORCID https://orcid.org/0000-0002-0740-7941
Najah AlsubaieDepartment of Computer Sciences, College of Computer and Information Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-6381-9019

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumors are one of the most fatal disorders that cause one of the highest mortalities in the world. Gliomas are the most common primary brain tumors originating from glial cells in the central nervous system. Traditionally, a tissue sample is extracted and examined for its genetic and characteristic properties. This method is invasive, painful, and takes a longer period to produce results. Various automatic Deep learning (DL) based schemes have been presented for the brain glioma detection, but they lack due to poor explainability, lower generalization, poor feature depiction, class imbalance problem and lower detection rate. This paper presents a deep learning based brain tumor detection using two way feature depiction model (TWFDM) that combines the 2D-Deep Convolution Neural Network (DCNN) and 1D-DCNN. The 2D-DCNN accepts the raw MRI images and the 1D-DCNN accepts the handcrafted local binary pattern (LBP), gray level cooccurrence matrix (GLCM), and Histogram of Oriented Gradient (HOG) features. Furthermore, improved particle swarm optimization (IPSO) is used for feature selection to minimize the computational complexity of the TWFDM system. The proposed TWFDM achieves an overall accuracy of 96.25%, a recall of 96.34%, a precision of 96.31%, and an F1-score of 96.32% on the Brain MRI dataset for four-class classification, representing an important improvement over traditional techniques.

Indexed as

Brain NeoplasmsDeep LearningGliomaAlgorithmsConvolutional Neural NetworksHumansMagnetic Resonance ImagingParticle Swarm Optimization

Identifiers

PMID42391295
PMCPMC13327244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.